Live Breaking News & Updates on David Lanfear

Stay updated with breaking news from David lanfear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Letters to the Editor (1/24/24)

'Carpetbagger' Candidate [Re "Former Middlebury Selectboard Member Announces Bid for Governor," January 5, online]: A 33-year-old from Connecticut running for governor of Vermont? Are you. ....

South Royalton , United States , Clarendon Springs , Anne Wallace Allen , David Lanfear , Eben Markowski , Nils Daulaire , Ben Lawrence , Jonathan Gibson , Fred Tuttle , Rob Mann , University Of Vermont Medical Center , Vermont Agency Of Agriculture , Man With , Vermont Agency , Green Water , Anne Wallace , Ace Mcarleton , What We Can , What We Can Afford , Johnson Woolen Mills , Seven Days , Mcneil Generating Station , Vermont Medical Center , Kampus Kitchen , Fair Game ,

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients

/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health. ....

United States , David Lanfear , Phil Febbo , David Mcalpine , Henry Ford , Illumina Inc , Christopher Jeffries Center , Drug Administration , World Health Organization , Genomic Medicine Research At Henry Ford Health , Henry Ford Health , American College Of Medical Geneticists , Clinical Pharmacogenetics Implementation Consortium , Division Of Cardiovascular Medicine At Henry Ford , Cardiovascular Medicine , Precision Medicine , Genomic Medicine Research , World Health , American College , Medical Geneticists ,

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas. ....

United States , Herb Aronow , Phil Febbo , Emily Henderson , David Lanfear , American College Of Medical Geneticists , World Health Organization , Translational Research At Henry Ford Health , Henry Ford Health , Drug Administration , Heart Vascular Services At Henry Ford Health , Clinical Pharmacogenetics Implementation Consortium , Christopher Jeffries Center , Genomic Medicine Research At Henry Ford Health , Illumina Inc , Ford Health , Cardiovascular Medicine , Henry Ford , Precision Medicine , Genomic Medicine Research , Vice President , Translational Research , Medical Director , Vascular Services , Chief Medical Officer , American College ,

Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients

The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US. ....

David Lanfear , Henry Ford , Drug Administration , Henry Ford Health , Clinical Pharmacogenetics Implementation Consortium , American College Of Medical Geneticists , Fulgent Genetics , American College , Medical Geneticists ,

V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure

The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure ....

David Lanfear , Neal Eigler , James Januzzi , Saibal Kar , Joann Lindenfeld , John Gorcsan , Richard Holcomb , Stephan Anker , Michael Zile , Williamt Abraham , Nasrien Ibrahim , Interatrial Shunt , Ventura Shunt , Breakthrough Device Designation , Chief Medical , Executive Committee , Josep Rod , Gregg Stone , Heart Failure Content , Heart Failure Takeaways , Reverse Remodeling , Heart Failure With Reduced Ejection Fraction , Advanced Heart Failure ,